Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors.

MLA

Sağlık, Begüm Nurpelin, et al. “Synthesis, in Vitro Enzyme Activity and Molecular Docking Studies of New Benzylamine-Sulfonamide Derivatives as Selective MAO-B Inhibitors.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 35, no. 1, Dec. 2020, pp. 1422–32. EBSCOhost, https://doi.org/10.1080/14756366.2020.1784892.

APA

Sağlık, B. N., Osmaniye, D., Acar Çevik, U., Levent, S., Kaya Çavuşoğlu, B., Atlı Eklioğlu, Ö., Özkay, Y., Koparal, A. S., & Kaplancıklı, Z. A. (2020). Synthesis, in vitro enzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1422–1432. https://doi.org/10.1080/14756366.2020.1784892

Chicago

Sağlık, Begüm Nurpelin, Derya Osmaniye, Ulviye Acar Çevik, Serkan Levent, Betül Kaya Çavuşoğlu, Özlem Atlı Eklioğlu, Yusuf Özkay, Ali Savaş Koparal, and Zafer Asım Kaplancıklı. 2020. “Synthesis, in Vitro Enzyme Activity and Molecular Docking Studies of New Benzylamine-Sulfonamide Derivatives as Selective MAO-B Inhibitors.” Journal of Enzyme Inhibition and Medicinal Chemistry 35 (1): 1422–32. doi:10.1080/14756366.2020.1784892.